Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 103

1.

Inhibition of SREBP With Fatostatin Does Not Attenuate Early Diabetic Nephropathy in Male Mice.

Van Krieken R, Marway M, Parthasarathy P, Mehta N, Ingram AJ, Gao B, Krepinsky JC.

Endocrinology. 2018 Mar 1;159(3):1479-1495. doi: 10.1210/en.2018-00093.

PMID:
29420703
2.

Pd-Catalyzed Aerobic Oxidation Reactions: Strategies To Increase Catalyst Lifetimes.

Ho WC, Chung K, Ingram AJ, Waymouth RM.

J Am Chem Soc. 2018 Jan 17;140(2):748-757. doi: 10.1021/jacs.7b11372. Epub 2018 Jan 5.

PMID:
29244945
3.

Which Patients With Atrial Fibrillation and Chronic Kidney Disease Should Receive Anticoagulation-And With Which Anticoagulant?

Hart RG, Ingram AJ, Eikelboom JW.

Can J Cardiol. 2017 Feb;33(2):211-213. doi: 10.1016/j.cjca.2016.10.007. Epub 2016 Oct 17. No abstract available.

PMID:
27998618
4.

Localizing Perturbations of the Racemic Equilibria Involving Dipicolinate-Derived Lanthanide(III) Complexes.

Nguyen BT, Ingram AJ, Muller G.

Chirality. 2016 Apr;28(4):325-31. doi: 10.1002/chir.22584. Epub 2016 Mar 3.

5.

Going beyond electrospray: mass spectrometric studies of chemical reactions in and on liquids.

Ingram AJ, Boeser CL, Zare RN.

Chem Sci. 2016 Jan 1;7(1):39-55. doi: 10.1039/c5sc02740c. Epub 2015 Oct 1.

6.

Catalytic Role of Multinuclear Palladium-Oxygen Intermediates in Aerobic Oxidation Followed by Hydrogen Peroxide Disproportionation.

Ingram AJ, Walker KL, Zare RN, Waymouth RM.

J Am Chem Soc. 2015 Oct 28;137(42):13632-46. doi: 10.1021/jacs.5b08719. Epub 2015 Oct 16.

PMID:
26444100
7.

Coronary artery calcification, cardiovascular events, and death: a prospective cohort study of incident patients on hemodialysis.

Wilkieson TJ, Rahman MO, Gangji AS, Voss M, Ingram AJ, Ranganath N, Goldsmith CH, Kotsamanes CZ, Crowther MA, Rabbat CG, Clase CM.

Can J Kidney Health Dis. 2015 Aug 12;2:29. doi: 10.1186/s40697-015-0065-6. eCollection 2015.

8.

Droplet spray ionization from a glass microscope slide: real-time monitoring of ethylene polymerization.

Jiang J, Zhang H, Li M, Dulay MT, Ingram AJ, Li N, You H, Zare RN.

Anal Chem. 2015 Aug 18;87(16):8057-62. doi: 10.1021/acs.analchem.5b02390. Epub 2015 Jul 27.

PMID:
26204485
9.

Trinuclear Pd₃O₂ intermediate in aerobic oxidation catalysis.

Ingram AJ, Solis-Ibarra D, Zare RN, Waymouth RM.

Angew Chem Int Ed Engl. 2014 May 26;53(22):5648-52. doi: 10.1002/anie.201400134. Epub 2014 Apr 7.

PMID:
24711099
10.

4-Phenylbutyrate inhibits tunicamycin-induced acute kidney injury via CHOP/GADD153 repression.

Carlisle RE, Brimble E, Werner KE, Cruz GL, Ask K, Ingram AJ, Dickhout JG.

PLoS One. 2014 Jan 8;9(1):e84663. doi: 10.1371/journal.pone.0084663. eCollection 2014.

11.

Modes of activation of organometallic iridium complexes for catalytic water and C-H oxidation.

Ingram AJ, Wolk AB, Flender C, Zhang J, Johnson CJ, Hintermair U, Crabtree RH, Johnson MA, Zare RN.

Inorg Chem. 2014 Jan 6;53(1):423-33. doi: 10.1021/ic402390t. Epub 2013 Nov 14.

PMID:
24228617
12.

Colchicine attenuates renal injury in a model of hypertensive chronic kidney disease.

Guan T, Gao B, Chen G, Chen X, Janssen M, Uttarwar L, Ingram AJ, Krepinsky JC.

Am J Physiol Renal Physiol. 2013 Nov 15;305(10):F1466-76. doi: 10.1152/ajprenal.00057.2013. Epub 2013 Aug 14.

13.

Stroke prevention in atrial fibrillation patients with chronic kidney disease.

Hart RG, Eikelboom JW, Brimble KS, McMurtry MS, Ingram AJ.

Can J Cardiol. 2013 Jul;29(7 Suppl):S71-8. doi: 10.1016/j.cjca.2013.04.005. Review.

PMID:
23790601
14.

Caveolin-1 deficiency protects against mesangial matrix expansion in a mouse model of type 1 diabetic nephropathy.

Guan TH, Chen G, Gao B, Janssen MR, Uttarwar L, Ingram AJ, Krepinsky JC.

Diabetologia. 2013 Sep;56(9):2068-77. doi: 10.1007/s00125-013-2968-z. Epub 2013 Jun 21.

PMID:
23793581
15.

TGFβ receptor I transactivation mediates stretch-induced Pak1 activation and CTGF upregulation in mesangial cells.

Chen G, Chen X, Sukumar A, Gao B, Curley J, Schnaper HW, Ingram AJ, Krepinsky JC.

J Cell Sci. 2013 Aug 15;126(Pt 16):3697-712. doi: 10.1242/jcs.126714. Epub 2013 Jun 18.

16.

Chemoselective Pd-catalyzed oxidation of polyols: synthetic scope and mechanistic studies.

Chung K, Banik SM, De Crisci AG, Pearson DM, Blake TR, Olsson JV, Ingram AJ, Zare RN, Waymouth RM.

J Am Chem Soc. 2013 May 22;135(20):7593-602. doi: 10.1021/ja4008694. Epub 2013 May 9.

PMID:
23659308
17.

Propagation of human prostate cancer stem-like cells occurs through EGFR-mediated ERK activation.

Rybak AP, Ingram AJ, Tang D.

PLoS One. 2013 Apr 19;8(4):e61716. doi: 10.1371/journal.pone.0061716. Print 2013.

18.

BRCA1 is a novel target to improve endothelial dysfunction and retard atherosclerosis.

Singh KK, Shukla PC, Quan A, Al-Omran M, Lovren F, Pan Y, Brezden-Masley C, Ingram AJ, Stanford WL, Teoh H, Verma S.

J Thorac Cardiovasc Surg. 2013 Oct;146(4):949-960.e4. doi: 10.1016/j.jtcvs.2012.12.064. Epub 2013 Feb 14.

19.

Anticoagulants in patients with atrial fibrillation and end-stage renal disease.

Brimble KS, Ingram AJ, Eikelboom JW, Hart RG.

Postgrad Med. 2012 Nov;124(6):17-25. doi: 10.3810/pgm.2012.11.2609. Review.

PMID:
23322135
20.

MicroRNA-145 targeted therapy reduces atherosclerosis.

Lovren F, Pan Y, Quan A, Singh KK, Shukla PC, Gupta N, Steer BM, Ingram AJ, Gupta M, Al-Omran M, Teoh H, Marsden PA, Verma S.

Circulation. 2012 Sep 11;126(11 Suppl 1):S81-90.

PMID:
22965997

Supplemental Content

Loading ...
Support Center